Abstract: The instant disclosure relates to hair-treatment compositions that include a unique combination of components that function to impart desirable cosmetic properties to the hair, especially chemically treated hair. The hair-treatment compositions typically include: at least 0.5 wt. % of at least one non-polymeric mono, di, or tricarboxylic acid, and/or a salt thereof; one or more amines; one or more alkoxysilanes; one or more cationic polymers; and water. Hair treated with the hair-treatment compositions is strengthened and exhibits improved sensorial properties such as smoothness, softness, and suppleness.
Type:
Grant
Filed:
May 24, 2017
Date of Patent:
March 3, 2020
Assignee:
L'OREAL
Inventors:
Kwana Patterson, Barbara Mitchell, Anand Mahadeshwar
Abstract: The invention relates to a transdermal therapeutic system (TTS), comprising a backing layer, which is permeable to the active ingredient, at least one matrix layer, comprising fentanyl or an active agent analogous to fentanyl, based on polyacrylate and a protective layer to be removed before usage, characterized in that the polyacrylate polymer is self-adhesive, free of carboxyl groups, has a saturation solubility for fentanyl of 3 to 20 wt. %, preferably of 4 to 12 and particularly of 5 to 10 wt. % and the layers contain at least 80% of the included active ingredient in a molecularly-dispersed, dissolved form.
Abstract: A dietary supplement composition as a prophylactic and treatment for skin diseases such as eczema and psoriasis and the like, the composition comprising a phase II liver detoxification component having glycine, and magnesium, wherein glycine and magnesium are present in the supplement composition in a ratio of between about 20:1 and 20:8.
Abstract: Disclosed is a cosmetic including polyether-based urethane foam impregnated with a cosmetic composition. The cosmetic provides improved feeling in use, portability and stability.
Type:
Grant
Filed:
September 24, 2013
Date of Patent:
January 21, 2020
Assignee:
Amorepacific Corporation
Inventors:
Kyung Nam Kim, Jung Sun Choi, Min Kyung Shim, Kyung Ho Choi, Yeong Jin Choi
Abstract: Provided is a polyether-based urethane foam for impregnating a cosmetic composition. The polyether-based urethane foam has excellent touch feel, portability and stability.
Type:
Grant
Filed:
December 17, 2018
Date of Patent:
January 21, 2020
Assignee:
Amorepacific Corporation
Inventors:
Kyung Nam Kim, Jung Sun Choi, Min Kyung Shim, Kyung Ho Choi, Yeong Jin Choi
Abstract: An aqueous suspension agrochemical composition is provided containing fenpyrazamine and an acid component. The composition has no problem of emission of odor and has excellent storage stability. The composition has a pH at 25° C. in a range of 2.5 to 6.5.
Abstract: The disclosure provides oral cysteamine and cystamine formulations useful for treating cystinosis and neurodegenerative diseases and disorders. The formulations provide controlled release compositions that improve quality of life and reduced side-effects.
Type:
Grant
Filed:
March 15, 2018
Date of Patent:
November 26, 2019
Assignee:
The Regents of the University of California
Abstract: There is provided a method for treating pigmented lesions comprising a composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant. The composition may further comprise at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
December 5, 2018
Date of Patent:
November 26, 2019
Assignee:
KLOX TECHNOLOGIES INC.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmacologically acceptable carrier.
Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
Type:
Grant
Filed:
September 8, 2017
Date of Patent:
November 12, 2019
Assignee:
ALK-Abelló A/S
Inventors:
Henrik Hugo Jacobi, Annette Rømmelmayer Lundegaard, Christian Gauguin Houghton, Jan Søndergaard-Andersen, Stig Asmul-Olsen, Lise Lund Mærkedahl
Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one drug or drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein a combination of the at least one drug being a limus drug and the at least one lipophilic antioxidant being butylated hydroxytoluene is excluded.
Abstract: A method of promoting hemostasis in the mouth or oral cavity utilizes a non-absorbent, low surface energy and highly conformable non-disruptive hemostasis material. Traditional wound packing material is highly absorbent and has large open surfaces that allow clot forming materials, such as the platelet plug to adhere to the packing material and whereupon removal, the clot is disrupted. A non-disruptive highly conformable hemostasis material does not have large open pores and therefore does not adhere to forming clots. A non-disruptive hemostasis material may consist of expanded polytetrafluoroethylene that has a pore size of no more than about 10 microns. A non-disruptive hemostasis material may comprise a thin film of material over a portion of the outside surface that is non-absorbent and thin to allow for conforming into an oral cavity, such as from a tooth extraction. A thin film may cover porous material, such as a foam, that may be elastomeric.
Abstract: Mineral, cosmetic, pharmaceutical, agricultural, nutraceutical, and other compositions are produced using a mineral composition containing minimal concentrations of cadmium, lead, arsenic, and mercury and containing relatively high concentrations of micro and macro mineral elements, of rare earth elements, of calcium, and of silica. The mineral concentrations are produced by processing naturally occurring clay soil to concentrate mineral elements naturally occurring in the soil.
Abstract: A method and apparatus for generating nano particles, including but not limited to nano particles of Ceo, at high concentration. The invention uses a solid aerosol disperser in communication with a furnace tube having a vaporization chamber and a dilution chamber. A heating element surrounds the furnace tube. Heat from the heating element heats bulk materials contained within a gas flow in the vaporization chamber to a temperature sufficient to convert the bulk materials to a vapor phase. Vaporized bulk materials are then moved to a dilution chamber, where an inert gas is introduced through a dilution gas port. The flow of the inert gas into the dilution chamber through the dilution gas port is sufficient to eject the bulk material from the exit of the dilution chamber, thereby condensing the bulk material into nano sized particles in a gas flow of sufficient volume to prevent agglomeration of the nano sized particles.
Type:
Grant
Filed:
November 6, 2017
Date of Patent:
August 27, 2019
Assignee:
Battelle Memorial Institute
Inventors:
Amit Gupta, William C. Forsythe, Mark L. Clark
Abstract: A wound dressing having anti-microbial activity comprises a first fiber capable of bonding with silver (1) cations. The wound dressing comprises a blend of the first fiber to which silver (1) cations are bonded and a second fiber which is substantially free from silver. The wound dressing comprises from 0.01 to 5.0 percent by weight of silver (1) cations, based on the weight of fiber.
Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.
Abstract: There is provided a wound healing composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin in association with a pharmaceutically acceptable carrier. In addition, a method of topically treating wounds using at least one oxidant and at least one photoactivator capable of activating the oxidant followed by illumination of said photosensitizer is disclosed.
Type:
Grant
Filed:
February 7, 2017
Date of Patent:
August 20, 2019
Assignee:
KLOX TECHNOLOGIES INC.
Inventors:
Remigio Piergallini, Nikolaos Loupis, Francesco Bellini
Abstract: The present invention relates to a compound of formula (I): wherein: R8 and R9, independently of each other, are hydrogen, fluorine or C1-C3alkyl; R10 is hydrogen or methyl (preferably hydrogen); and the other substituents are as defined herein; and wherein the compound of formula (I) is optionally present as an agrochemically acceptable salt thereof. These compounds are thought to be suitable for use as herbicides. The invention therefore also relates to a method of controlling weeds, especially grassy monocotyledonous weeds, in crops of useful plants, comprising applying a compound of formula (I), or a herbicidal composition comprising such a compound, to the plants or to the locus thereof.
Type:
Grant
Filed:
June 3, 2014
Date of Patent:
August 13, 2019
Assignee:
Syngenta Limited
Inventors:
Ian Henry Aspinall, Stephane Andre Marie Jeanmart, James Nicholas Scutt, John Benjamin Taylor
Abstract: A method for increasing collateral circulation includes providing a pharmaceutically acceptable synthetic cerebrospinal fluid that has a density different than that of the patient's naturally-occurring cerebrospinal fluid. The synthetic cerebrospinal fluid includes a vasodilator. The method further includes administering the synthetic cerebrospinal fluid to an intrathecal space of a patient through a lumbar access point to reach the intrathecal space of a patient.
Abstract: The invention relates to the production and application of a biological inoculant for use in plant material sown in nurseries. The invention also relates to a method for the immobilization of bacterial strains on a support and application to plant materials. The invention further relates to the use of native teak tree rhizosphere bacteria as a means for promoting plant growth. The invention consists in developing a biological product based on applying rhizosphere bacteria to a carbonized teak sawdust support, which can be used to obtain plants with improved characteristics in less time.
Type:
Grant
Filed:
April 10, 2014
Date of Patent:
August 6, 2019
Assignee:
PONTIFICIA UNIVERSIDAD JAVERIANA
Inventors:
Lucía Ana Diaz, Lina Marcela Morales Palencia, Juan Sebastian P. Beltran Acosta